Bartoll-Roca, X, Mari-Dell'Olmo, M, Gotsens, M, Palencia, L, Perez, K, Diez, E, Borrell, C. Neighbourhood income inequalities in mental health in Barcelona 2001-2016: a Bayesian smoothed estimate. Gaceta Sanitaria. 2022; 36(6)DOI:10.1016/j.gaceta.2022.03.007. PMID:35644735. IF:1.900(Q3/8D).

Esmel-Vilomara, R, Dolader, P, Giralt, G, Ferrer, Q, Gran, F. Coxsackievirus-induced myocarditis. ANALES DE PEDIATRIA. 2022; 97(5)DOI:10.1016/j.anpedi.2022.01.007. PMID:35995700. IF:2.100(Q3/6D).

Zapata, L, Suarez-Montero, JC, Flores-Orella, MN, Morales-Alarcon, EM, Segarra, A, Santos-Rodriguez, JA. Acute cor pulmonale in patients with acute respiratory distress syndrome due to COVID-19. Medicina Intensiva. 2022; 46(11)DOI:10.1016/j.medin.2021.12.016. PMID:35079192. IF:3.000(Q3/7D).

Pinter, A, Puig, L, Schakel, K, Reich, A, Zaheri, S, Costanzo, A, Tsai, TF, Smith, SD, Lynde, C, Brnabic, A, Reed, C, Hill, J, Schuster, C, Riedl, E, Paul, C. Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(11)DOI:10.1111/jdv.18376. PMID:35766124. IF:9.200(Q1/1D).

Le, AM, Puig, L, Torres, T. Deucravacitinib for the Treatment of Psoriatic Disease. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2022; 23(6)DOI:10.1007/s40257-022-00720-0. PMID:35960487. IF:7.300(Q1/1D).

Torres, T, Puig, L, Vender, R, Yeung, J, Carrascosa, JM, Piaserico, S, Gisondi, P, Lynde, C, Ferreira, P, Bastos, PM, Dauden, E, Leite, L, Valerio, J, del Alcazar-Viladomiu, E, Rull, EV, Llamas-Velasco, M, Pirro, F, Messina, F, Bruni, M, Licata, G, Ricceri, F, Nidegger, A, Hugo, J, Mufti, A, Daponte, AI, Teixeira, L, Balato, A, Romanelli, M, Prignano, F, Gkalpakiotis, S, Conrad, C, Lazaridou, E, Rompoti, N, Papoutsaki, M, Nogueira, M, Chiricozzi, A. Drug Survival of Interleukin (IL)-17 and IL-23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi-country, Multicentric Cohort Study. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2022; 23(6)DOI:10.1007/s40257-022-00722-y. PMID:35976568. IF:7.300(Q1/1D).

Wollenberg, A, Kinberger, M, Arents, B, Aszodi, N, Valle, GA, Barbarot, S, Bieber, T, Brough, HA, Pinton, PC, Christen-Zach, S, Deleuran, M, Dittmann, M, Dressler, C, Fink-Wagner, AH, Fosse, N, Gaspar, K, Gerbens, L, Gieler, U, Girolomoni, G, Gregoriou, S, Mortz, CG, Nast, A, Nygaard, U, Redding, M, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Flohr, C. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(11)DOI:10.1111/jdv.18429. PMID:36056736. IF:9.200(Q1/1D).

Lopez-Ferrer, A, Vilarrasa, E, Armesto, S, Santos-Juanes, J, Galache, C, Carretero, G, Sahuquillo, A, Salgado-Boquete, L, del Alcazar, E, Gonzalez-Cantero, A, Martorell, A, Rivera-Diaz, R, Mitxelena-Ezeiza, J, Mateu, A, Belinchon, I, Llamas-Velasco, M, Riera-Monroig, J, Lazaro, A, Lopez-Estebaranz, JL, Gich, I, Puig, L. Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study. Dermatologic Therapy. 2022; 35(11)DOI:10.1111/dth.15831. PMID:36109488. IF:3.600(Q1/3D).